Ventas Inc., US92276F1003

Ventas stock holds after $1.73 billion quarter

Published on 08/19/2026 at 19:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Ventas stock is trading off its recent 52-week high after quarterly revenue reached $1.73 billion and EPS came in at $0.97.

Trading-Floor mit Händlern vor Bildschirmen, die Healthcare- und Immobilien-Charts zeigen
Ventas Inc. (US92276F1003) wird an der NYSE gehandelt, Editorial-Foto zeigt Trading-Floor mit Healthcare- und Immobiliencharts, Illustration mit AI erstellt.

Ventas Inc. (US92276F1003) reported quarterly revenue of $1.73 billion and earnings per share of $0.97 in the latest reported quarter, while the stock was quoted at $89.11 on August 19, 2026. The same report showed revenue up 21.7% year over year and EPS ahead of the $0.96 consensus by $0.01.

Quarterly numbers matter

The quarterly update also pointed to a market capitalization of $46.80 billion, a 52-week range of $66.38 to $101.60, and a beta of 0.69. The comparison is straightforward: revenue rose from $1.42 billion in the prior-year quarter to $1.73 billion, while EPS improved from $0.87 to $0.97.

That mix leaves investors focused on how much of the latest growth can carry into the next report. Analysts on average expect full-year earnings of $3.89 per share, which frames the quarter as a useful checkpoint rather than a finish line.

Valuation and trading range

At $89.11, the shares were below the recent high of $101.60 and above the low of $66.38, with the latest snapshot also showing a price-to-earnings ratio of 168.96 and a PEG ratio of 2.11. The market value and the wide trading band matter more here than a single session move, because Ventas is still being measured against a large healthcare-REIT base.

That valuation gap helps explain why the stock can react to small changes in earnings quality, not just the revenue headline. For a company of this size, even a $0.01 EPS beat and a 21.7% revenue increase can reset short-term sentiment.

Healthcare REIT exposure

Ventas owns healthcare real estate across senior housing, outpatient and other care-linked assets, which makes occupancy, rent collections and financing costs central to its earnings profile. The latest quarter's scale - $1.73 billion in revenue and $0.97 in EPS - shows why the operating mix matters as much as the headline growth rate.

More on Ventas shares: the company remains tied to the healthcare property cycle, where asset quality and tenant demand often matter as much as broad market sentiment.

Stock snapshot

Ventas stock traded at $89.11 on August 19, 2026, according to the latest market snapshot, with a market cap of $46.80 billion and a 52-week range of $66.38 to $101.60.

Fact box

Company: Ventas Inc.
ISIN: US92276F1003
Ticker: VTR
Exchange: NYSE
Price (as of August 19, 2026, 7:57 a.m. ET): $89.11 USD
Market cap: $46.80 billion (as of August 19, 2026)
Sector / Industry: Real Estate / Healthcare REITs
Index membership: S&P 500

Disclaimer...

en | US92276F1003 | VENTAS INC. | boerse | 69971884 | bgmi